Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Treatment of hepatitis C virus infection in the future.

Kanda T, Yokosuka O, Omata M.

Clin Transl Med. 2013 Apr 11;2(1):9. doi: 10.1186/2001-1326-2-9.

PMID:
23577631
[PubMed]
Free PMC Article
2.

[Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].

Hunyady B, Kovács B, Battyáni Z.

Orv Hetil. 2011 Dec 11;152(50):1997-2009. doi: 10.1556/OH.2011.29266. Review. Hungarian.

PMID:
22112373
[PubMed - indexed for MEDLINE]
3.

New direct-acting antivirals' combination for the treatment of chronic hepatitis C.

Asselah T, Marcellin P.

Liver Int. 2011 Jan;31 Suppl 1:68-77. doi: 10.1111/j.1478-3231.2010.02411.x. Review.

PMID:
21205141
[PubMed - indexed for MEDLINE]
4.

Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.

Perry CM.

Drugs. 2012 Mar 26;72(5):619-41. doi: 10.2165/11208370-000000000-00000. Review.

PMID:
22439668
[PubMed - indexed for MEDLINE]
5.

Therapeutic vaccines against hepatitis C virus.

Xue J, Zhu H, Chen Z.

Infect Genet Evol. 2014 Mar;22:120-9. doi: 10.1016/j.meegid.2014.01.008. Epub 2014 Jan 23.

PMID:
24462908
[PubMed - in process]
6.

Hepatitis C virus NS5A inhibitors and drug resistance mutations.

Nakamoto S, Kanda T, Wu S, Shirasawa H, Yokosuka O.

World J Gastroenterol. 2014 Mar 21;20(11):2902-12. doi: 10.3748/wjg.v20.i11.2902.

PMID:
24659881
[PubMed - in process]
Free PMC Article
7.

Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.

Butt AA, Kanwal F.

Clin Infect Dis. 2012 Jan 1;54(1):96-104. doi: 10.1093/cid/cir774. Epub 2011 Dec 7. Review.

PMID:
22156853
[PubMed - indexed for MEDLINE]
Free Article
8.

Direct-acting antivirals for the treatment of chronic hepatitis C: open issues and future perspectives.

Chae HB, Park SM, Youn SJ.

ScientificWorldJournal. 2013 Jun 5;2013:704912. doi: 10.1155/2013/704912. Print 2013. Review.

PMID:
23844410
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow.

Asselah T, Marcellin P.

Liver Int. 2012 Feb;32 Suppl 1:88-102. doi: 10.1111/j.1478-3231.2011.02699.x. Review.

PMID:
22212578
[PubMed - indexed for MEDLINE]
10.

Managing HIV/hepatitis C co-infection in the era of direct acting antivirals.

Rockstroh JK, Bhagani S.

BMC Med. 2013 Nov 1;11:234. doi: 10.1186/1741-7015-11-234.

PMID:
24228933
[PubMed - in process]
Free Article
11.

Formulary management of the protease inhibitors boceprevir and telaprevir for chronic hepatitis C virus.

Tungol A, Rademacher K, Schafer JA.

J Manag Care Pharm. 2011 Nov;17(9):685-94. Review.

PMID:
22050393
[PubMed - indexed for MEDLINE]
Free Article
12.

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H Jr, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT; APRICOT Study Group.

N Engl J Med. 2004 Jul 29;351(5):438-50.

PMID:
15282351
[PubMed - indexed for MEDLINE]
Free Article
13.

Treatment for Hepatitis C Virus Infection in Adults [Internet].

Chou R, Hartung D, Rahman B, Wasson N, Cottrell E, Fu R.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov.

PMID:
23304740
[PubMed]
Books & Documents
14.

Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.

Hartwell D, Jones J, Baxter L, Shepherd J.

Health Technol Assess. 2011 Apr;15(17):i-xii, 1-210. doi: 10.3310/hta15170. Review.

PMID:
21473834
[PubMed - indexed for MEDLINE]
Free Article
15.

Telaprevir for previously untreated chronic hepatitis C virus infection.

Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S; ADVANCE Study Team.

N Engl J Med. 2011 Jun 23;364(25):2405-16. doi: 10.1056/NEJMoa1012912.

PMID:
21696307
[PubMed - indexed for MEDLINE]
Free Article
16.

Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus.

Pawlotsky JM.

Hepatology. 2011 May;53(5):1742-51. doi: 10.1002/hep.24262. Review.

PMID:
21374691
[PubMed - indexed for MEDLINE]
17.

The beginning of the end: what is the future of interferon therapy for chronic hepatitis C?

Feld JJ.

Antiviral Res. 2014 May;105:32-8. doi: 10.1016/j.antiviral.2014.02.005. Epub 2014 Feb 15.

PMID:
24548815
[PubMed - in process]
18.

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, Morand P, Goujard C, Pialoux G, Piroth L, Salmon-Céron D, Degott C, Cacoub P, Perronne C; ANRS HCO2 RIBAVIC Study Team.

JAMA. 2004 Dec 15;292(23):2839-48.

PMID:
15598915
[PubMed - indexed for MEDLINE]
19.

[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].

Zuckerman E, Safadi R, Oren R, Shibolet O, Baruch Y, Bruck R, Lurei Y, Kaspa RT, Abu-Mouch S, Shouval D, Ben-Ari Z; Israeli Association for the Study of the Liver.

Harefuah. 2012 Dec;151(12):709-14, 719. Hebrew.

PMID:
23330266
[PubMed - indexed for MEDLINE]
20.

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients.

Ramachandran P, Fraser A, Agarwal K, Austin A, Brown A, Foster GR, Fox R, Hayes PC, Leen C, Mills PR, Mutimer DJ, Ryder SD, Dillon JF.

Aliment Pharmacol Ther. 2012 Mar;35(6):647-62. doi: 10.1111/j.1365-2036.2012.04992.x. Epub 2012 Feb 1.

PMID:
22296568
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk